International law firm McDermott Will & Schulte represented members of the Mills family and affiliated entities in connection with the $6.26 billion IPO of Class A common stock of Medline Inc. (Nasdaq: MDLN), which ranks as the largest IPO of 2025 and one of the largest private equity-backed IPOs of all time.

Medline has served customers in the healthcare industry for over 50 years and was founded in 1966 by Jim and Jon Mills. Following the closing of the IPO, Charles Mills will serve as chair of Medline’s board of directors, with Andrew Mills serving as a director and James Abrams as a board observer.

The McDermott team was led by Eric Orsic and Richard Lang and included Daniel Zucker, Gary Karch, and Charles Darantiere.

About Medline

Medline is the largest provider of medical-surgical products and supply chain solutions serving all points of care. Through its broad product portfolio, resilient supply chain and leading clinical solutions, Medline helps healthcare providers improve their clinical, financial and operational outcomes. Headquartered in Northfield, Illinois, the company employs more than 43,000 people worldwide and operates in more than 100 countries.

Leading organizations turn to global law firm McDermott Will & Schulte for a better way to address legal challenges, connect with those at the forefront, and drive stronger outcomes. Working across more than 20 offices globally, our 1,750+ lawyers act on data-driven insights, deep relationships, and unmatched industry experience to deliver on our commitment of Always Better.